Adam Crystal
President, R&D · 10 filings · Latest: Aug 3, 2026
Tango Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TNGX | ADAM CRYSTAL | — | Feb 25, 2026 | Proposed Sale | $12.88 | 54,345 | $700.0K | — | |
TNGX | Adam Crystal | President, R&D | Feb 3, 2026 | Sale | $12.26 | 18,452 | $226.3K | 187,218 |
← Previous
Page 2 of 2